Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both sides of the Atlantic.

President Donald Trump said he planned to implement a 50% duty on copper imports as part of a set of looming sectoral tariffs, while also indicating he could offer pharmaceutical manufacturers at least a year before applying a crippling 200% tariff on their foreign-made products.